"How can a drug to treat claudication in adults save preterm newborns?"

Serife Kurul¹, Karel Allegaert^{2

3}, Robert B Flint^{1

4}, H Rob Taal¹

Affiliations

¹ Department of Pediatrics, Division Neonatology, Erasmus University Medical Center, Rotterdam, Netherlands.
² Department of Development and Regeneration and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. karel.allegaert@uzleuven.be.
³ Department of Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands. karel.allegaert@uzleuven.be.
⁴ Department of Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.

Editorial

Serife Kurul et al. Eur J Pediatr. 2020 Aug.

. 2020 Aug;179(8):1331-1334.

doi: 10.1007/s00431-020-03631-6.

Serife Kurul¹, Karel Allegaert^{2

3}, Robert B Flint^{1

4}, H Rob Taal¹

¹ Department of Pediatrics, Division Neonatology, Erasmus University Medical Center, Rotterdam, Netherlands.
² Department of Development and Regeneration and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. karel.allegaert@uzleuven.be.
³ Department of Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands. karel.allegaert@uzleuven.be.
⁴ Department of Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.

No abstract available

Keywords: Drug repurposing; Neonatal; Pentoxifylline; Sepsis.

Comment on

Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis.
Schüller SS, Kempf K, Unterasinger L, Strunk T, Berger A. Schüller SS, et al. Eur J Pediatr. 2020 Aug;179(8):1325-1330. doi: 10.1007/s00431-020-03612-9. Epub 2020 Mar 16. Eur J Pediatr. 2020. PMID: 32179980